VRML News and Press, Aspira Womens Health From 11/17/19

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) had a bit of a rocky week, but managed to stay in the green over the course of the trading period.  The index opened last Monday (November 11) at 3,459.2 points before reaching 3,492.46 points as of 1:33 p.m. EST on Friday (November 15)...

Vermillion, Inc. (VRML) Q3 2019 Earnings Conference Call November 12, 2019 4:30 P.M. ET Company Participants Valerie Palmieri - President and Chief Executive Officer Chris Goulart - Senior Vice President of Commercial Operations Bob Beechey - Chief Financial Officer Conference...

Vermillion (NASDAQ: VRML ): Q3 GAAP EPS of -$0.04. Revenue of $1.29M (+67.5% Y/Y) Press Release More news on: Vermillion, Inc., Earnings news and commentary, Healthcare stocks news, ,

AUSTIN, Texas, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the third quarter ended September 30, 2019. “We are very pleased by the c...

AUSTIN, Texas, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the three and nine months ended September 30, 2019 on Tuesday, No...

AUSTIN, Texas, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management will participate in one-on-one meetings at the 2019 Cantor Global Healthcare Conference, t...

- Milestone data announced during Ovarian Cancer Awareness Month, which demonstrates OVA1’s superior sensitivity of ovarian cancer risk detection in both Caucasian and African American women versus other testing options, CA125 or ROMA- Vermillion, Inc. (Nasdaq: VRML), a bioana...

Vermillion, Inc. (VRML) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Valerie Palmieri – President and Chief Executive Officer Bob Beechey – Chief Financial Officer Chris Goulart – Senior Vice President of Commercial Operatio...

Vermillion (NASDAQ: VRML ): Q2 GAAP EPS of -$0.06. More news on: Vermillion, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

AUSTIN, Texas, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the second quarter ended June 30, 2019. “We are very pleased by the conti...